FNF Insiders Net Sell $7M as Analysts Target 39% Upside
Fidelity National Financial trades at 7.6 times forward earnings with Wall Street analysts targeting a 39% premium to today's price—yet company insiders, including its Chief Legal Officer, have collec
FNF Insiders Net Sell $7M as Analysts Target 39% Upside
NEW YORK, September 13 —
Fidelity National Financial, Inc. (FNF) trades at 7.6 times forward earnings while Wall Street analysts set a consensus target of $61.40—39% above the current $44.13, yet the company's own insiders spent the last 90 days selling, not buying, $7.15 million in shares with zero purchases recorded. The contradiction demands an explanation.
- Q2 2026 EPS of $1.39 beat consensus by 5.3%, per FNF's August 5 earnings 8-K.
- Trailing free cash flow of $3.59B against $4.02B in cash and $4.78B in total debt.
- CLO Peter Sadowski sold 69,196 shares at $45.70 on June 26, above the stock's current price.
The Discount That Insiders Won't Buy
FNF, the Jacksonville-based title insurance and annuities conglomerate, generates $15.35 billion in trailing revenue, up 10.5% year-over-year. Its Title segment underwrites real estate closings; its F&G unit sells indexed annuities and pension risk transfer solutions. At 7.6x forward earnings with $3.59B in free cash flow, the screen looks compelling. But a valuation gap of this magnitude in a well-covered financial usually means one of two things: the market sees a cycle risk analysts are discounting, or the stock is genuinely cheap. The insider activity tilts the reading toward the former. Director Halim Dhanidina's $3.99M sale on June 24 and CLO Sadowski's $3.16M exit two days later together account for the full $7.15M net outflow, and not one insider stepped in to buy at these levels.
Why the CLO's Exit Price Is the Detail That Matters
Sadowski sold at $45.70, above FNF's current $44.13. That spread is narrow, but the direction is pointed: FNF's top legal officer, with full visibility into the company's regulatory exposure, litigation posture, and deal pipeline, treated the mid-$45 range as an exit rather than a hold. The earnings record complicates the picture: two consecutive misses of 6.0% and 14.7% in Q4 2025 and Q1 2026 preceded the Q2 beat, a pattern consistent with a business sensitive to rate-driven real estate volumes that can turn quickly. Title insurance revenue is essentially a toll on transaction activity; when mortgage rates suppress deal flow, the toll booth goes quiet. Insiders know the forward booking pipeline before analysts do.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| FNF | $11.8B | 7.6x | -23.8% |
| FAF | $7.3B | 9.7x | +7.6% |
| FIS | $19.7B | 5.7x | -43.0% |
| ORI | $9.9B | 12.4x | +2.7% |
| STC | $2.0B | 9.1x | -11.0% |
| UNM | $14.9B | 10.0x | +26.1% |
What Closes the Gap, or Confirms It
The bull case rests on cycle recovery: a drop in mortgage rates lifting real estate transaction volumes, which would flush cash through FNF's Title segment and justify the analyst consensus. The specific number that tests that thesis is Q3 2026 Title segment revenue: if it accelerates materially from Q2, the 7.6x multiple starts to look like an oversight. If it stagnates, the insiders' read looks prescient. With 84.9% institutional ownership and short interest at just 2.8%, there is no short-squeeze setup here; the stock will move on fundamentals, not positioning. Run the free Fidelity National Financial, Inc. deep-dive →
Current fundamentals, valuation and filing history for Fidelity National Financial, Inc. (FNF) are tracked on its Basis Report page.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Fidelity National Financial trades at 7.6 times forward earnings with Wall Street analysts targeting a 39% premium to today's price—yet company insiders, including its Chief Legal Officer, have collectively net sold $7.15 million in shares with zero purchases over the last 90 days, at prices at or above the current trading level.